- Home
- VSTM vs AGL Comparison
VSTM vs AGL Comparison
Compare VSTM & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.50
HOLD
Current Price
$0.46
Company Overview
Basic Information| Metric | VSTM | AGL |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.7M | 422.9M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VSTM | AGL |
|---|---|---|
| Price | $5.50 | $0.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 14 |
| Target Price | ★ $15.00 | $2.66 |
| AVG Volume (30 Days) | 1.5M | ★ 4.6M |
| Earning Date | 03-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $30,914,000.00 | ★ $5,932,576,000.00 |
| Revenue This Year | $282.16 | N/A |
| Revenue Next Year | $72.63 | $5.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 209.14 | N/A |
| 52 Week Low | $4.01 | $0.34 |
| 52 Week High | $11.25 | $6.08 |
Technical Indicators
Market Signals| Indicator | VSTM | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 39.18 |
| Support Level | $4.01 | $0.34 |
| Resistance Level | $6.79 | $0.73 |
| Average True Range (ATR) | 0.40 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 12.50 | 9.02 |
Price Performance
Historical Comparison VSTM
AGL
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.